FITC Anti-Mouse CD19 (1D3) | Cytek Biosciences
Dynabeads™ CD19 Pan B
Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19+ hematologic indications - Cytotherapy
Human CD19 Separation Beads | Biocompare.com Kit/Reagent Review
CD19 MicroBeads, human | CD19 Microbeads | human | Products | Miltenyi Biotec | USA
Enrichment and expansion of anti‐CD19 CAR‐T cells with aAPCs or beads.... | Download Scientific Diagram
Anti-Human CD19 Magnetic Particles - DM
Magnetic selection for consistent cellular starting material in autologous cell therapy manufacture
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial | Nature Medicine
Positive Selection of Mouse B Cells from Single-cell Suspensions of Spleen | Biocompare.com Kit/Reagent Review
Low-affinity CAR T cells exhibit reduced trogocytosis, preventing rapid antigen loss, and increasing CAR T cell expansion | Leukemia
Simplified process for the production of anti–CD19-CAR–engineered T cells - Cytotherapy
Beads for Research | ProMab
Anti-Human CD19 Magnetic Particles - DM
Anti-rabbit CD19 Recombinant Antibody – Cobalt Biologics
Multiplexing single cell measurement of CAR-T cells in microchambers. a... | Download Scientific Diagram
Frontiers | Cytokines induced memory-like NK cells engineered to express CD19 CAR exhibit enhanced responses against B cell malignancies
CD19：a validated therapeutic target for B-cell malignancies - ACROBiosystems
Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus: Molecular Therapy Methods & Clinical Development
Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies | Hematology, Transfusion and Cell Therapy
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
Establishing CD19 B-cell reference control materials for comparable and quantitative cytometric expression analysis | PLOS ONE
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies - ScienceDirect
Cancers | Free Full-Text | CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity
